- ►shouxi.net NJ Olsen, CM Stein - The New England journal of medicine, 2004 - nejm.org Specific CD4+ T cells are involved in the induction of the immune response in
rheumatoid arthritis, most likely as a response to an unknown exogenous or
endogenous antigen. Consequently, recruited monocytes, macrophages, and ... Cited by 418 - Related articles - BL Direct - All 13 versions
- ►shouxi.net JR O'Dell - New England Journal of Medicine, 2004 - content.nejm.org The diagnosis cannot be established by a single laboratory test or procedure but
is aided by the use of seven diagnostic criteria 16 that favor clinical factors
and, therefore, depend on the clinician's asking insightful questions and ... Cited by 290 - Related articles - BL Direct - All 17 versions
B Combe, R Landewe, C Lukas, HD Bolosiu, F … - British Medical Journal, 2007 - ard.bmj.com Methods: In accordance with EULAR's "standardised operating procedures", the
task force pursued an evidence based approach and an approach based on expert
opinion. A steering group comprised of 14 rheumatologists representing 10 ... Cited by 169 - Related articles - BL Direct - All 5 versions
KG Saag, GG Teng, NM Patkar, J Anuntiyo, C … - Arthritis Rheum, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 129 - Related articles - All 2 versions
- ►oxfordjournals.org C Metzler, C Fink, P Lamprecht, WL Gross, E … - Rheumatology, 2004 - Br Soc Rheumatology Methods. This was a Phase II, single-centre, open-label clinical investigation
of patients with generalized WG treated with leflunomide after the induction of
complete (n = 4) or partial (n = 16) remission by ... Cited by 114 - Related articles - BL Direct - All 6 versions
- ►aspetjournals.org BN Cronstein - Pharmacological reviews, 2005 - ASPET Methotrexate administered weekly in low doses is a mainstay in the therapy of
rheumatoid arthritis. Although originally developed as a folate antagonist for
the treatment of cancer, its mechanism of action in the therapy of ... Cited by 91 - Related articles - BL Direct - All 10 versions
JR Kalden, M Schattenkirchner, H Sörensen, … - Arthritis Care & Research - interscience.wiley.com Patients with rheumatoid arthritis (RA) who received leflunomide (100 mg/day for
3 days, 10 mg/day or 20 mg/day thereafter) in the 2 phase III studies and who
completed 2 years of treatment were offered inclusion in the open-label ... Cited by 75 - Related articles - BL Direct - All 5 versions
F Goldblatt, DA Isenberg - Clinical and experimental immunology, 2005 - pubmedcentral.nih.gov Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disease, which
continues to cause significant morbidity in affected persons. In the past few
years, a number of new exciting therapeutic options have become available. ... Cited by 73 - Related articles - All 5 versions
- ►bmj.com [PDF] A Zink, JD Listing, S Kary, P Ramlau, M … - British Medical Journal, 2005 - ard.bmj.com Online First articles must include the digital object identifier (DOIs) and date
of initial establish publication priority; they are indexed by PubMed from
initial publication. Citations to may be posted when available prior to ... Cited by 56 - Related articles - BL Direct - All 9 versions
